ENG 
R&D Team
United by Our Commitment
Venom’s R&D team brings together elite professionals from diverse fields, including molecular biology, pharmacology, and bioengineering. With a focus on the study of snake-derived biological resources, the team has established a comprehensive technical framework spanning from basic research to clinical translation. The team specializes in analyzing the active components of snake venom and utilizes techniques such as gene sequencing and protein structure modeling to identify potential molecules for the treatment of cancer and cardiovascular and cerebrovascular diseases.
In the fields of protein modification and recombinant protein expression, the team has overcome numerous technical challenges to establish a highly efficient and stable engineered bacterial expression system, providing a solid foundation for novel drug development. Guided by the belief of “Exploring the Unknown, Safeguarding Health,” they work tirelessly in the laboratory day and night. From screening the bioactive components of snake-derived traditional Chinese medicines to designing nucleic acid therapeutics, every step embodies rigor and innovation as they strive to advance the translation of scientific research into clinical applications.
Emerging Technologies
Snake venom is a mixture composed primarily of highly pharmacologically active proteins and peptides.
Snake venom exhibits high catalytic efficiency, thermal stability, and resistance to proteolytic hydrolysis, making it an ideal research model for biochemists and structural biologists.
Snake venom has a wide range of cutting-edge applications. In medicine, its components have anti-cancer, anti-thrombotic, and anti-neurodegenerative properties, as well as analgesic and antibacterial effects; some of these applications have entered clinical trials. In the field of cosmetics, snake venom-mimicking peptides are used for wrinkle reduction.
Snake venom is rich in proteins, peptides, and other toxins that can target various ion channels, cell receptors, and membrane transporters.
Compared to traditional small-molecule drugs, snake venom proteins and peptides exhibit greater specificity and affinity for their targets, making them particularly suitable for novel drug design.
In the medical aesthetics industry, which prioritizes both safety and efficacy, snake venom proteins and peptides have emerged as star ingredients in the new generation of anti-aging and skin repair products due to their unique biological activity.
Some snake venom-mimicking peptides are used in cosmetics to reduce dynamic wrinkles. The mechanism likely involves inhibiting the release of neurotransmitters to reduce muscle contractions, thereby reducing wrinkles; however, their cosmetic benefits are limited, requiring long-term use, and results vary from person to person.
合作单位
专利展示
